Platelet monoamine oxidase B activity in 'de novo' and L-dopa treated parkinsonian patients and controls

Canadian Journal of Neurological Sciences

Volumn 25, Issue 3, 1998, Pages 249-251

  Kuhn, Wilfried ^a   Müller, Thomas ^a   Gerstner, Anja ^a   Winkel, Regina ^a   Goetz, Mario E ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIPARKINSON AGENT; BENSERAZIDE; CARBIDOPA; LEVODOPA; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; TREATMENT OUTCOME;

EID: 0031874215     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100034090     Document Type: Article

References (23)

1. Riederer P, Konradi C, Schay V, et al. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl. Adv Neurol 1987; 45: 111-118.
2. Konradi C, Riederer P, Jellinger K, Denney R. Cellular action of MAO inhibitors. J Neural Transm Suppl 1987; 25: 15-25.
3. Koide Y, Koide N, ROSS S, Sääf J, Wetterberg L. Monoamine oxidase in human platelets. Kinetics and methodological aspects. Biochem Pharmacol 1981; 30: 2893-2900.
4. Checkoway H. Costa LG, Woods JS, et al. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1992; 4: 283-290.
5. Cohen G. Monoamine oxidase, hydrogen peroxide, and Parkinson's Disease. In: Yahr MD, Bergmann KJ, eds. Advances in Neurology. New York: Raven Press, Vol 45; 1986: 119-125.
6. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721.
7. Riederer P, Konradi C, Hebenstreit G, Youdim MBH. Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand 1989; 80 (Suppl 126): 41-45.
8. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
9. Wurtman RJ, Axelrod J. A sensitive and specific assay for the estimation of monoamine oxidase. Biochem Pharmacol 1963; 12: 1439-1441.
10. Tipton KF, Youdim MBH. The assay of monoamine oxidase. In: Parvez S, Nagatsu T, Nagatsu I, Parvez H, eds. Methods Biogenic Amine Res, Amsterdam: Elsevier, 1983: 441-465.
11. Mann JJ, Stanley M, Kaplan RD, Sweeney J, Neophytides A. Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. J Neurol Neurosurg Psychiatry 1983; 46: 905-910.
12. Zeller EA, Boshes B, Arbit J, et al. Molecular biology of neurological and psychiatric disorders. I. Effects of Parkinsonism, age, sex, and L-Dopa on platelet monoamine oxidase. J Neural Transm 1976; 176; 39: 63-77.
13. Steventon GB, Sturman SG, Heafield MTE, et al. Platelet monoamine oxidase B in Parkinson's Disease. J Neural Transm PD Sect 1989; 1: 255-261.
14. Jarman J, Glover V, Sandler M, Turjanski N, Stern G. Platelet monoamine oxidase B activity in Parkinson's Disease: a reevaluation. J Neural Transm PD Sect 1993; 5: 1-4.
15. Sandler M, Glover V, Clow A, Jarman J. Monoamine oxidase-B inhibitors and Parkinson's disease. A role for superoxide dismutase? In: Narabayashi H, Nagatsu T. Yanagisawa N, Mizuno Y, eds. Advances in Neurology, New York: Raven Press, 1993: 238-241.
16. Lee DH, Mendoza M, Dvorozniak MT, et al. Platelet monoamine oxidase in Parkinson patients: effect of 1-deprenyl therapy. J Neural Transm PD Sect 1989; 1: 189-194.
17. Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multiinfarct dementia. Acta Psychiatr Scand 1988; 78: 730-736.
18. Humfrey CDN, Steventon G.B, Sturman SG, et al. Monoamine oxidase substrates in Parkinson's disease. Biochem Pharmacol 1990; 40: 2562-2564.
19. Steventon G, Humfrey C, Sturman S, Waring RH, Williams AC. Monoamine oxidase B and Parkinson's disease. Lancet 1990; 20: 180.
20. Kuiper MA, Konings CH, Bergmans PLM, Wolters E Ch. Monoamine oxidase-B activity in untreated and treated Parkinson patients. In: Abstracts of the 10th International Symposium on Parkinson's disease, 1991; Tokyo: 182.
21. Kurth JH, Kurth MC, Poduslo SE, Schankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993; 33: 368-372.
22. Hotamisligil GS, Girmen AS, Fink JS, et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's Disease. Mov Disord 1994; 9: 305-310.
23. Ho SL, Kapadi L, Ramsden DB, Williams AC. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995; 37: 403-405.